Multiple Outcomes of Raloxifene Evaluation (MORE) Trial. Serum estradiol level and risk of breast cancer during treatment with raloxifene. - Cummings,S.R.; Duong,T.; Kenyon,E.; Cauley,J.A.; Whitehead,M.; Krueger,K.A. (JAMA, 2002)